IBM Stock Slumps on Profit-Taking Amid CHIPS Act Milestone
IBM's stock fell by 3.1% in morning trading on Tuesday as investors locked in gains from an extended rally, which had seen shares surge approximately 40% since late-July lows.
The move stands out against a technology sector that is largely holding its ground, pointing to stock-specific selling pressure rather than a broad tech selloff.
The primary driver behind the decline appears to be profit-taking after IBM's Anderon subsidiary finalized a $1 billion research and development award under the CHIPS and Science Act with the U.S. Department of Commerce.
Investors had been fueling the rally with excitement around this milestone, but now that it has been confirmed, they are rotating out of the position in a classic 'buy the rumor, sell the news' fashion.